tiprankstipranks
Trending News
More News >
Impact BioMedical, Inc. (IBO)
:IBO
US Market

Impact BioMedical, Inc. (IBO) Income Statement

Compare
101 Followers

Impact BioMedical, Inc. Income Statement

Last quarter (Q1 2025), Impact BioMedical, Inc.'s total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Impact BioMedical, Inc.'s net income was C$-1.27M. See Impact BioMedical, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 2.33MC$ 0.00C$ 50.00KC$ 50.00KC$ 0.00
Gross Profit
C$ 2.33MC$ 0.00C$ 50.00KC$ 50.00KC$ 0.00
Operating Expenses
C$ 1.78MC$ 4.03MC$ 3.45MC$ 3.45MC$ 1.14M
Depreciation and Amortization
C$ 343.46KC$ 1.12MC$ 1.11MC$ 1.11MC$ 1.14M
EBITDA
C$ -1.54MC$ -2.84MC$ -6.30MC$ -6.30MC$ 0.00
Operating Income
C$ 551.66KC$ -4.03MC$ -3.40MC$ -3.40MC$ -1.14M
Other Income/Expenses
C$ -2.60MC$ -379.00KC$ -4.47MC$ -4.47MC$ 0.00
Pretax Income
C$ -2.05MC$ -4.41MC$ -7.88MC$ -7.88MC$ -1.14M
Net Income
C$ -2.05MC$ -4.34MC$ -7.05MC$ -7.05MC$ -760.07K
Per Share Metrics
Basic EPS
C$ -0.01C$ -0.01C$ -0.61C$ -0.61C$ -0.01
Diluted EPS
C$ -0.01C$ -0.01C$ -0.61C$ -0.61C$ -0.01
Weighted Average Shares Outstanding
41.75M 191.30M 11.50M 11.50M 70.50K
Weighted Average Shares Outstanding (Diluted)
41.75M 191.30M 11.50M 60.25M 70.50K
Currency in CAD

Impact BioMedical, Inc. Earnings and Revenue History